Difference between revisions of "Imajo M, et al. EMBO J. (2012) cited as Ref 176 in DOI: 10.1038/s41392-020-0110-5 (Q9439)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 1109-1122, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): Miyamoto A, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | Miyamoto A | ||
| Property / Fourth Author string: Miyamoto A / rank | |||
| + | Normal rank | ||
Revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Imajo M, et al. EMBO J. (2012) cited as Ref 176 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Imajo M
0 references
Miyatake K
0 references
Iimura A
0 references
2012
0 references
EMBO J.
0 references
31
0 references
A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling (English)
0 references
1109-1122
0 references
Miyamoto A
0 references
